HALO — Halozyme Therapeutics, Inc. stock price, charts and financials

QT74Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
112.45
+2.77+2.53%
OverviewShort InterestFilings
HALOQT74Halozyme Therapeutics, Inc.·NASDAQ
112.45+2.53%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 18, 20268-KCurrent report
Sep 17, 20264Statement of changes in beneficial ownership
Sep 16, 20268-KCurrent report
Sep 11, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Aug 21, 20263Initial statement of beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 18, 20268-KCurrent report
Aug 11, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 09, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 09, 20263Initial statement of beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 11, 202610-QQuarterly report
May 11, 20268-KCurrent report
May 07, 20264Statement of changes in beneficial ownership
#1 / 25 of 351
Page
▼
/ 15